youtube_live
Q3 2026 earnings • released • EPS miss -31.91% • Revenue beat +4.77%
See resultschevron_right
XPEV:NYSE
Xpeng Inc - ADR
$8.51
arrow_downward
-9.32%(-0.88) 1D
Nov 20, 11:10:16 AM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for XPEV...
Open
$9.11
High
$9.12
Low
$8.43
Mkt. cap
8.45B
Avg. vol.
7.77M
Volume
6.89M
52-wk high
$21.99
52-wk low
$8.43
EPS
-$0.57
Beta
0.96
Shares outstanding
785.11M
No. of employees
21K
Open
$9.11
High
$9.12
Low
$8.43
Mkt. cap
8.45B
Avg. vol.
7.77M
Volume
6.89M
52-wk high
$21.99
52-wk low
$8.43
EPS
-$0.57
Beta
0.96
Shares outstanding
785.11M
No. of employees
21K
News stories
From web sources and news partners
Benzinga
·
2 hours ago
This WW Grainger Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
The Globe and Mail
·
13 hours ago
Analysts Offer Insights on Consumer Cyclical Companies: XPeng, Inc. ADR (XPEV), Amer Sports, Inc. (AS) and Viking Holdings (VIK)
Zacks
·
1 day ago
XPeng Stock Down 52% YTD: Is This a Buying Opportunity?
About Xpeng Inc - ADR
CEO-
Employees20.6K
Founded2015
Headquarters-
SectorConsumer Discretionary
IndustryCar
Websitexiaopeng.com
Analyst ratings
Based on 11 analysts giving stock ratings to XPEV in the past 3 months
Buy
Buy
6
Hold
4
Sell
1
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for XPEV in the last 3 months.
Highest
Current $8.51
$28.00 (+229.02%)
Average
$15.50 (+82.14%)
Lowest
$10.00 (+17.51%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Yuqian Ding HSBC | Hold | Downgraded | $10.10 | +18.7% | 11/20/2026 |
Ming-Hsun Lee Bank of America Securities | Buy | Maintained | $16.00 | +88% | 11/18/2026 |
Ji Shi CMB International Securities | Buy | Maintained | $15.00 | +76.3% | 11/17/2026 |
Jiong Shao Barclays | Sell | Maintained | $12.00 | +41% | 11/17/2026 |
Roman Lukianchikov Freedom Capital Markets | Buy | Maintained | $20.00 | +135% | 11/17/2026 |
Eunice Lee Bernstein | Hold | Reiterated | $15.00 | +76.3% | 11/16/2026 |
Jeff Chung Citi | Buy | Maintained | $16.40 | +92.7% | 11/18/2026 |
Nick Lai J.P. Morgan | Hold | Maintained | $10.00 | +17.5% | 10/29/2026 |
Tina Hou Goldman Sachs | Buy | Reiterated | $16.00 | +88% | 10/23/2026 |
Neil Beveridge Bernstein | Hold | Maintained | $18.00 | +111.5% | 10/12/2026 |
Paul Gong UBS | Hold | Reiterated | $12.00 | +41% | 09/09/2026 |
Unknown Analyst DBS | Buy | Maintained | $28.00 | +229% | 08/25/2026 |
Unknown Analyst UBS | Hold | Maintained | - | - | 08/12/2026 |
Unknown Analyst Goldman Sachs | Buy | Maintained | $20.00 | +135% | 08/03/2026 |
Eugene Hsiao Macquarie | Buy | Upgraded | $19.00 | +123.3% | 05/28/2026 |
Johnson Wan Jefferies | Buy | Reiterated | $26.50 | +211.4% | 03/25/2026 |
Unknown Analyst Jefferies | Buy | Reiterated | $26.50 | +211.4% | 03/25/2026 |
Bo Pei CFA US Tiger Securities | Hold | Downgraded | $20.00 | +135% | 03/20/2026 |
Tim Hsiao Morgan Stanley | Buy | Maintained | $34.00 | +299.5% | 03/09/2026 |
Last report
Nov 16, 2026
Fiscal period
Q3 2026
- Normalized EPS / Est. (CNY)
- GAAP EPS / Est. (CNY)
-CN¥0.93 / -CN¥0.70
-31.91%miss
arrow_downward
Revenue / Est. (CNY)
24.28B / 23.17B
+4.77%beat
arrow_upward
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in CNY | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
Revenue | 22.25B | 13.03B | 19.74B | 24.28B |
Cost of goods sold | 17.40B | 10.35B | 15.66B | 19.68B |
Cost of revenue | 17.40B | 10.35B | 15.66B | 19.68B |
Research and development expenses | 2.87B | 2.91B | 2.91B | 2.85B |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 2.79B | 1.88B | 2.50B | 2.78B |
Operating expense | 4.83B | 4.61B | 5.27B | 5.51B |
Total operating expenses | 22.23B | 14.96B | 20.93B | 25.19B |
Operating income | 24.47M | -1.93B | -1.19B | -914.52M |
Other non operating income | 22.17M | -1.06M | 49.37M | 90.39M |
EBT including unusual items | 405.34M | -1.77B | -1.26B | -842.95M |
EBT excluding unusual items | 208.70M | -2.00B | -1.17B | -807.52M |
Income tax expense | 22.13M | 9.25M | 74.28M | 25.02M |
Effective tax rate | 5.46% | -0.52% | -5.88% | -2.97% |
Other operating expenses | -839.69M | -182.25M | -137.25M | -114.62M |
Net income | 383.21M | -1.78B | -1.34B | -867.98M |
Net profit margin | 1.72% | -13.69% | -6.77% | -3.58% |
Earnings per share | 0.52 | -0.88 | -0.65 | -0.46 |
Interest and investment income | 262.92M | 257.17M | 216.75M | 245.20M |
Interest expense | -76.48M | -164.99M | -124.47M | -119.60M |
Net interest expenses | 186.43M | 92.17M | 92.27M | 125.60M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 593.24M | -1.36B | -621.42M | -345.75M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events